Centre Of Research Excellence In Medicines Intelligence
Funder
National Health and Medical Research Council
Funding Amount
$2,500,000.00
Summary
The NHMRC Centre of Research Excellence in Medicines Intelligence is a co-ordinated research program that will accelerate the development and translation of evidence on prescribed medicines use and outcomes for regulators and payers. The CRE is perfectly placed to embrace the national ‘call to action’ from the Health Minister's recent announcement to establish Quality Use of Medicine Safety as a National Health Priority.
Activation Of BMP4 Signalling To Inhibit Breast Cancer Metastasis
Funder
National Health and Medical Research Council
Funding Amount
$748,742.00
Summary
The spread of cancer cells to other organs is a common cause of breast cancer-related death in women. Current therapies for advanced breast cancer are often palliative since the secondary tumours become resistant to the chemotherapy. Here, we are using preclinical models of advanced breast cancer to develop a treatment that should be effective in patients with secondary tumours and should reduce the risk of dying of this disease.
Multidrug Resistance Protein 1 Inhibitors To Sensitise Cancers To Chemotherapy
Funder
National Health and Medical Research Council
Funding Amount
$840,166.00
Summary
Multidrug resistance protein 1 (MRP1) is often present at high levels in cancer cells, where it pumps chemotherapy drugs back out, causing drug resistance. Inhibitors that block MRP1 would increase the effectiveness of chemotherapy. We have developed MRP1 inhibitors with promising activity in cancer cells and mouse tumours and will now develop these inhibitors for clinical application and commercialisation.
Challenges to moral responsibility. Agents deserve various kinds of benefits and burdens (such as punishment) only if they are morally responsible for their actions. This project aims to assess several sorts of alleged threats to our moral responsibility, and thereby to better the social allocation of goods to individuals.
ADAM Metalloprotease Inhibition For Treatment Of Colorectal Cancer
Funder
National Health and Medical Research Council
Funding Amount
$770,925.00
Summary
Colorectal cancer (CRC) causes over 4000 deaths/year, typically from developing drug resistance and spreading to other organs (metastasis). These processes involve tumour cells called cancer stem cells (CSCs), which rely on specific cell surface proteins for survival and function. We are developing antibodies against one of these type of proteins, to test in mouse models of CRC. These already show promise in targeting CSCs and inhibiting drug-resistance and metastasis in mice.
Conscience and conscientious objection in health care. Medical professionals sometimes decline to provide particular forms of safe, beneficial and legal health care, on the grounds that provision would go against their consciences. Bioethicists and policy makers have failed to identify legitimate limits to the scope of appeals to conscientious objection in health care. This is in large part because the underlying concept ''conscience" is unclear. This project aims to advance bioethical debate by ....Conscience and conscientious objection in health care. Medical professionals sometimes decline to provide particular forms of safe, beneficial and legal health care, on the grounds that provision would go against their consciences. Bioethicists and policy makers have failed to identify legitimate limits to the scope of appeals to conscientious objection in health care. This is in large part because the underlying concept ''conscience" is unclear. This project aims to advance bioethical debate by producing a philosophically and psychologically informed analysis of conscience, and by applying this to discussions about the legitimate limits to conscientious objection in health care. It is expected to result in academic and non-academic publications and enable improvements to Australian health care policy.Read moreRead less
Discovery Early Career Researcher Award - Grant ID: DE200100511
Funder
Australian Research Council
Funding Amount
$398,521.00
Summary
Human and Artificial Agents: A Unified Account of Agency. This project aims to develop philosophical and scientifically informed criteria for deciding whether artificial agents can be responsible for their behaviour. The project’s significance lies in the fact that artificial agents are becoming increasingly prevalent in contemporary society but raise moral problems, which the project aims to address. Expected outcomes include influencing how artificially intelligent agents (especially moral one ....Human and Artificial Agents: A Unified Account of Agency. This project aims to develop philosophical and scientifically informed criteria for deciding whether artificial agents can be responsible for their behaviour. The project’s significance lies in the fact that artificial agents are becoming increasingly prevalent in contemporary society but raise moral problems, which the project aims to address. Expected outcomes include influencing how artificially intelligent agents (especially moral ones) are built, and addressing questions about who is legally liable or responsible for the harms that may be caused by such systems. The anticipated benefit is a comprehensive account of agency that can guide development of artificial agents and inform our dealings with such agents in society and in the law.Read moreRead less
Re-EValuating The Inhibition Of Stress Erosions (REVISE): Gastrointestinal Bleeding Prophylaxis In ICU
Funder
National Health and Medical Research Council
Funding Amount
$2,955,164.00
Summary
Around 50,000 patients in Australian Intensive Care Units receive a drug called pantoprazole each year with the aim of preventing bleeding from the gut. Recent research suggests this practice is ineffective and may harm patients by increasing their risk of serious infections. We will perform a definitive study to determine whether the widespread use of pantoprazole is beneficial or harmful.
Mechanisms Of Glucocorticoid Resistance In Acute Lymphoblastic Leukaemia
Funder
National Health and Medical Research Council
Funding Amount
$547,970.00
Summary
Glucocorticoids are extremely active drugs used in the treatment of childhood acute lymphoblastic leukaemia (ALL), yet a proportion of patients respond poorly to therapy and exhibit resistance at relapse. Clinically relevant mechanisms of glucocorticoid resistance are poorly understood, principally due to lack of appropriate experimental models. This project will reveal novel mechanisms of drug resistance in childhood leukaemia and lead to novel therapeutic strategies to improve outcome.
Moral conservatism, human enhancement and the 'Affective Revolution' in moral psychology. Debates between moral conservatives and liberals, about whether enhancing human mental and physical abilities above normal limits is ethically acceptable, have been intractable. Recent developments in moral psychology can be used to transform understandings of these debates and enable us to develop just policies to regulate enhancement technologies.